Picton Mahoney Asset Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3M Buy
56,286
+22,675
+67% +$1.21M 0.03% 278
2025
Q1
$1.36M Buy
+33,611
New +$1.36M 0.02% 252